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ABSTRACT

To produce doxorubicin and its analogues methyl 3al

pha, 5alpha-dihydroxy-5beta-(trimethylsilylethynyl)-

2alpha-nitromethylcyclohexane-1beta-carboxylate

acetonide is condensed with 1,4-dihydro-4,4,5-trime
thoxy-1-oxonaphthalene in the presence of 1,8diazabicyclo-5.4.0]undec-7-ene in an aprotic solvent to

produce 3-(2beta-carbomethoxy-4-beta-ethynyl-4-alpha,
6alpha-(di-O-isopropylidenyl)cyclohexanyl-1-yl)nitromethyl-4,4,5-trimethoxy-1-oxo-1,2,3,4-tetrahy
dronaphthalene; which is cyclized to produce 9beta
ethynyl-12-hydroxy-7alpha,9alpha-(di-O-iso
propylidenyl)-6-nitro-4,5,5-trimethoxy-5,5a,6-

6a,7,8,9,10,10a,11-decahydro -11-naphthacenone. The
decahydro-11-naphthacenone is converted to 7alpha
9alpha,(di-O-isopropyl-idenyl)-4,5-dimethoxy-9beta
ethynyl-12-hydroxy-6-nitro-6,6a,7,8,9,10,10a, 11
octahydro-11, -naphthacenone. The octahydro-11
naphthacenone is oxidized to 7alpha-9alpha, (di-O-iso

propyl-idenyl)-9beta-ethynyl-11-hydroxy-4-methoxy-6nitro-7,8,9,10-tetrahydro-5,12-naphthacenedione

which is converted to 6-desoxy-6-nitrodaunomycinone,
daunomycinone and related 6-substituted analogues of
daunomycinone.
37 Claims, No Drawings

1.

5,200,513

2
ate. The latter can be converted to daunomycinone and
many of its derivatives.
More specifically, this process for the production of
daunomycinone, comprises the steps of: (1) condensing

PROCESSES FOR PRODUCING DOXORUBICIN,
DAUNOMYCINONE, AND DERIVATIVES OF
DOXORUBCN

methyl 3alpha,5alpha-dihydroxy-5beta-(trimethylsilyle
thynyl)-2alphanitromethylcyclohexane-1-beta-carboxy
late acetonide with 1,4-dihydro-4,4,5-trimethoxy-1oxonaphthalene in the presence of 1,8-diazabicy
cloS.40-undec-7-ene in an aprotic solvent to produce

BACKGROUND OF THE INVENTION

This invention relates to a process for producing
doxorubicin (adriamycin), and derivatives of doxorubi

cin, through a novel synthesis of daunomycinone and its
derivatives. These mycinones can be coupled by known
methods to daunosamine to produce doxorubicin and its
corresponding derivatives.
It is known that doxorubicin is isolated from Strepto

myces peucetius. A suitable process for this isolation is
described by F. Arcamone, in "Duxorubicin Anticancer

O

a 3-(2beta-carbomethoxy-4-beta-ethynyl-4-alpha,6alpha
(di-O-isopropylidene)cyclohexanyl-1-yl-nitromethyl
44; 5-trimethoxy-1-oxo-1,2,3,4-tetrahydronaphthalene;

15

Antibiotics,” (Academic Press, New York (1981).
Moreover, synthetic routes to doxorubicin are known
and these are summarized, for example, by F. Arca
mone (loc. cit.), K. Krohn, Angew. Chem. Int, Ed. Engl,
volume 25 (1986), page 790 and Tetrahedron, volume 46
(1989), page 291 and T. R. Kelly, Tetrahedron Symposi
um-in-Print, volume 40 (1984), pages 4537-4793.
A representative prior art procedure for converting

pha,9alpha-(di-O-isopropylidenyl)-9beta-ethynyl-12
hydroxy-6-nitro-6,6a,7,8,9,10,10a-octahydro-11-naph

thacenone; (4) oxidizing the thus produced octahydro
11-naphthacenone

to

7alpha-9alpha-(di-O-isol

propylidenyl)-9beta-ethynyl-l-hydroxy-4-methoxy-6-

nitro-7,8,9,10-tetrahydro-5-12-naphthacenedione; (5)
hydrolysing the tetrahydro-5,12-naphthacenedione to

daunomycinone to adriamycin is that proposed by Ar 25
camone et al., U.S. Pat. No. 3,803,124. The prior art
methods of obtaining daunomycinone have the disad
vantage of being expensive.

SUMMARY OF THE INVENTION

30

It is an object of the invention to provide a novel
synthesis of doxorubicin.
It is a still further object of the invention to provide a
novel process for synthesis of derivatives of doxorubi

35

C.

(2) cyclizing the thus-produced 1-oxotetrahydronaph
thalene to produce 7alpha, 9alpha-(di-O-isopropylin
denyl)-4-6-nitro-4,5,5-trimethoxy-5,5a,6,6a,7,8,9,10,10a, 11-dechydro-11-naphthacenone; (3) converting
the decahydro-11-naphthacenone to 4,5-dimethoxy-7al

6-desoxy-6-nitro-daunomycinone; (6) reducing the nitro
compound to 6-desoxy-6-aminodaunomycinone; (7)
diazotising the amino compound and obtaining from it,
daunomycinone, the 6-desoxy-6 halo and
cyanodaunomycinones and compounds derived from
them.
To produce the methyl 3alpha,5alpha-dihydroxy-2al
pha-nitromethyl-5beta-(trimethylsilylethynyl)cyclohex
ane-1beta carboxylate, methyl cis-3,5-dihydroxy-5-

(trimethylsilylethynyl)-cyclohex-1-ene-1-carboxylate is

It is a still further object of the invention to provide a
novel process for the synthesis of doxorubicin and its
derivatives in which the A ring is made stereo selec
tively with its functionality already established and then
joined to the CD portion, with the relationship between
the C-7 and C-9 hydroxyls established stereoselectively
before the tetracyclic skeleton is constructed.
It is a still further object of the invention to provide a
novel process for the synthesis of daunomycinone that 45

proceeds in DCAB order with the Bring formed last.
It is a still further object of the invention to provide a
novel process of producing intermediates for the syn
thesis of daunomycinone, namely, methyl 3alpha,5al
pha-dihydroxy-5beta-(trimethylsilylethynyl)-2alpha
nitromethylcyclohexane-1-beta-carboxylate and the
3,5-acetonide of methyl 3alpha,5alpha-dihydroxy
5beta-(tri-methylsilylethynyl)-2alpha-nitromethylcy
clohexane-1-betacarboxylate.
It is a still further object of the invention to provide 55
novel synthetic routes to daunomycinone and deriva

reacted with nitromethane in the presence of 1,8diazabicyclo[5.4.0]undec-7-ene or sodium hydride in an
aprotic solvent that can act as a hydrogen bond accep
tor.
To synthesize methyl cis-3,5-dihydroxy-5-(trimethyl
silylethynyl)cyclohex-1-ene-1-carboxylate, m-anisic
acid is subject to the Birch reduction with lithium in
ammonia to produce 5-oxocyclohex-2-ene-1-carboxylic
acid, followed by methylation of thusproduced cy
clohex-2-ene-1-carboxylic acid to methyl 5-oxocy
clohex-2-ene-1-carboxylate with diazomethane, trime
thylsilyl-ethynylation of thus-produced cyclohex-2-ene
1-carboxylate with cerium dichloride trimethylsilylace
tylene to produce methyl cis-5-hydroxy-5-(trimethyl
silylethynyl)cyclohex-2-ene-1-carboxylate, conversion
to an epoxide and opening of the resulting epoxide ring
to produce the cis-3,5-dihydroxy compound.
In this process for synthesizing daunomycinone there

are several especially significant procedural steps, such

as: (1) the reaction mixture is kept between -20 to 20
degrees centigrade during esterification with diazo
methane; (2) any ethanol and water present in the esteri
fication reaction mixture is removed by azeotropic dis
tives of this compound.
In accordance with the invention a novel synthesis of tillation with benezene to produce methyl ester; (3)
daunomycinone is provided in which the A-ring precur methyl ester is immediately treated with cerium dichlo
sor of the compound is synthesized from m-anisic acid. 60 ride trimethylsilylacetylene at a low temperature, such
The A-ring precursor, methyl cis-2,3-epoxy-5-hydroxy as -50 to -78 degrees centigrade, to prevent forma
5-(trimethylsilylethynyl)cyclohexane-1-carboxylate, is tion of a lactone; (4) the epoxide is formed by oxidation
converted to methyl cis-3,5-dihydroxy-5-(trimethyl with tert-butylhydroperoxide in the presence of molyb
silylethynyl)cyclohex-1-ene-1-carboxylate which is ni denum hexacarbonyl catalyst and the epoxide that is
tromethylated to produce the required 2alpha 65 produced is isolated; and (5) the thus-formed epoxide
nitromethyl compound. The 3,5-acetonide of the 2al ring is opened with 1,8-diazabicyclo[5.4.0-undec-7-ene.
pha-nitromethyl compound is coupled with a juglone The cerium reagent must be added to the keto ester to
alkyl ether ketal and cyclized to a tetracyclic intermedi avoid a migration of the double bond.

5,200,513

3
A feature of the synthesis is the production of the
4,4-dimethylacetal of 5-alkoxy-1,4-naphthoquinones
oxidation of 5-alkoxy-1-naphthol with iodobenzene

4.
-continued
aO

MeOOC

diacetate in methanol. The 5-alkoxy-1-naphthol, in

which the alkoxy is of 1-6 carbon atoms as described in

: Cl2CeCeCSi(CH3)3/THF

Moore, H. W.; Lee, S.; Rutolo, D.; Sheldon, R., J. Org.
Chem., 1978, 43, 2304-2306. Generally, this process
may include the steps of: (1) alkylating 1,5-dihydrox

ynaphthalene with an excess of alkyl iodide in the pres
ence of a base, e.g. potassium carbonate in an aprotic
solvent to produce 1,5-dialkoxynaphthalene; (2) dealk
ylating the thus-produced 1,5-dialkoxynaphthalene

(2) NHC
10

MeOOC

CESiMe3

OH

o

with an alkali metal alkanethiolate to remove selec

tively one alkyl moiety; and (3) acidifying the alkoxide
that is produced to form 5-alkoxy-1-naphthol.
As can be understood from the above description, the

15

MeOOC

CeCSiMe3
OH

processes of this invention permit the manufacture of
doxorubicin less expensively and permit the effective 20
preparation of derivatives thereof.

(77%)

DETAILED DESCRIPTION

CHART 2.

The synthesis of the intermediate, required for elabo
ration of the A-ring, 3alpha,5alpha-dihydroxy-2alpha 25
nitromethyl-5beta-(trimethylsilylethynyl)cyclohexane
beta-carboxylate acetonide is shown in charts i and 2.
It has been found that a 58 percent overall yield of
methyl cis-3,5-dihydroxy-5-(trimethylsilylethynyl)cy 30
clohex-1-ene-1-carboxylate can be obtained by keeping
the reaction mixture cold during esterification with

diazomethane and removing any ethanol and water
present in the esterification reaction mixture by azeo
tropic distillation with benzene; quickly reacting to the 35
thus-produced methyl ester with added cerium dichlo
ride trimethylsilyl-acetylene at a low temperature to
prevent formation of a lactone; forming the epoxide by
oxidation with tert-butyl hydroperoxide in a fluxing
benzene solution in the presence of molybdenum hex
acarbonyl catalyst and isolating the thus-produced ep

MeOOC

CeCSiMe3

OH
(70%)
O

puche
MeOOC

CECSiMe3
OH

(93%)

o
MeNO2/DBU/DMSO
MeOOC

CECSiMe3

oH

oxide and opening the thus-formed epoxide ring with

^

1,8-diazabicyclo-5.4.0-undec-7-ene. Without the re
cited precautions and using completely anhydrous ce 45
rium dichloride, the yield from m-anisic acid is less than
10 percent.
Methyl 3alpha,5alpha-dihydroxy-2alpha-nitrometh

yl-5beta-(trimethylsilylethynyl)-cyclohexane-1beta-car
boxylate was obtained from methyl cis

(40%)

No oth

Se: CH2/

pyridinium tosylate
MeOOC

CeCSiMe3

o

N

CHART 1

HOOC C OMe

(100%)

(89%)

55

2,3-epoxy-5-hydroxy-5-(trimethylsilylethynyl)
(1) Li/NH3
(2) NHC

(3) H3O+

HOOC

aO

O 85%-90%

just

cy

clohexane-1-carboxylate by reaction with nitromethane
in the presence of 1,8-diazabicyclo[5.4.0-undec-7-ene in

65

an aprotic solvent that can serve as a hydrogen bond
acceptor. Alternatively, methyl 3alpha,5alpha-dihy
droxy-2alpha-nitromethyl-5beta-(trimethylsilylethynyl)
cyclohexane-1betacarboxylate was obtained from
methyl cis-3,5-dihydroxy-5-(trimethylsilylethynyl)cy
clohex-1-ene-1-carboxylate-and nitromethane in the
presence of 1,8-diazabicyclo-5.4.0-undec-7-ene or so
dium hydride in an aprotic solvent.
The aprotic solvent used for the nitromethylation
reaction may be selected from the following: hexame

5,200,513

5
thylphosphoramide, dimethyl sulfoxide and NN'dimethyl-NN'-propylene urea. The preferred aprotic
solvent is dimethyl sulfoxide. Nitromethane also adds to
the 3,5-di-(terbutyldinnethylsilyl) ether of the diol.
The nitromethylation is conveniently carried out at
ambient temperature for a time necessary to complete
the reaction. The required time is of the order of 12 to
24 hours. If the reaction becomes exothermic, cooling
to 15 to 25 degrees centigrade is preferred.
An acetonide is formed from 3alpha,5alpha-dihy

-continued
CHART 3
O

MeO
MeO

O

15

presence of a catalyst, such as pyridinium tosylate or
n-toluenesulfonic acid. A preferred catalyst is pyridin
ium tosylate.

quired to alkylate both hydroxyl groups. Preferably, a
molar ratio in the range of 4:1 to 2.5:1 of alkyl iodide to
1,5-dihydroxynaphthalene, is used. Most preferably, the
ratio is about 3.5:1.

-

The acetonide-forming reaction is carried out in the

of only one alkyl to give 5-alkoxy-1-naphthol. The alkyl

bon atoms, such as methyl, ethyl and n-propyl. The
alkyl iodide is used in an amount in excess of that, re

2-methoxypropene. Preferably, the acetonide-forming
reagent is 2-methoxypropene.

OMe

moiety can be selected from primary alkyls of 1-6 car

droxy-5beta-(trimethylsilylethynyl)-2alpha-nitrome

thylcyclohexane-libeta-carboxylate by treatment with
an acetonide-forming reagent. Representative aceto
nide-forming agents include, but are not limited to,

6

20

An inert solvent is used for the reaction. Benzene,

heptane, toluene are representative of solvents suitable 25
for the reaction. When benzene is used as the solvent,

The etherification reaction is conducted in the pres
ence of a base, which is normally selected from organic
and inorganic bases. Representative bases include, but
are not limited to, sodium carbonate, potassium carbon
ate, sodium hydroxide, potassium hydroxide, pyridine,
triethylamine. A preferred base is potassium carbonate.
The amount of base employed should be in the range of
3.5 moles to 4.5 moles, per mole of 1,5-dihydroxynaph
thalene.

the reaction goes to completion within a few minutes'
The aprotic solvent can be selected from acetone,
heating under reflux. Conditions appropriate for other methylethyl ketone, methylisobutyl ketone, tetrahydro
solvents can be determined by routine experimentation. 30 furan, acetonitrile, dimethyl sulfoxide. Preferably, the
The synthesis of a representative 1,4-dihydro-4,4,5- solvent is acetone.
The alkali metal alkanethiolate, used for removing
trimethoxy-1-oxo-naphthalene is shown in Chart 3. The
alkyl group from the intermediate dialkoxy com
initial steps of the synthesis include alkylation of both one
pound
can be selected from sodium and potassium al
hydroxyl groups of 1,5-dihydroxynaphthalene, fol 35 kanethiolates,
having 1-6 carbon atoms in the alkane
lowed by selective removal
moiety. Preferably, the alkali metal alkanethiolate is
sodium methanethiolate or ethanethiolate. The resulting
alkali metal alkoxide can be acidified with any mineral
acid, of which sulfuric acid, hydrochloric acid and

CHART 3
OH

HO

45

scover

OMe

phosphoric acid are representative.
The 5-alkoxy-1-napthol produced in this way can be
converted, for example, to a corresponding juglone
alkyl ether 4-ethylene ketal by reaction with ethylene
glycol and thallium trinitrate or lodobenzediacetate in
trimethyl orthoformate. A preferred ketal for down
stream synthesis is 1,4-dihydro-4,4-ethylenedioxy-5methoxy-1-oxonaphthalene, produced from 5-methoxy
1-naphthol and ethylene glycol under the conditions
stated.
A most preferred product for downstream synthesis
is 1,4-dihydro-4,4,5-trimethoxy-i-oxonaphthalene. This
is preferably produced from 5-methoxy-1-naphthol by
reaction with methanol and iodobenzene diacetate in

trimethyl orthoformate. It will be understood that alka

OMe

55

(1) NaSEt/DMSO
(2) H+
OH

nols of 2-3 carbon atoms can be used to produce higher
ketals by a similar process.
The synthesis of daunomycinone from methyl 3al
pha,5alpha-dihydroxy-2alpha-nitromethyl-5beta(trime
thylsilylethynyl)cyclohexane-1beta carboxylate aceto
nide and a representative 1,4-dihydro-44-5-trimethoxy
1-oxonaphthalene is shown in Chart 4. Condensation to
the 1-oxotetrahydronaphthalene is carried out in an
aprotic solvent. The aprotic solvent may be selected

OMe

65

notococo

from dimethyl sulfoxide, hexamethylphosphoramide
and acetonitrile. Acetonitrile is preferred. The reaction
is carried out at ambient temperature. Conversion to a
representative intermediate, 3-(2beta-carbomethox

ybeta-ethynyl-4-alpha,6alpha-(di-O-isopropylidenyl)-

5,200,513

8
pyridinium p-toluenesulfonate is preferred. A variety of
aprotic solvents e.g. aromatic hydrocarbons, tetrahy
drofuran, methylene chloride may be used; methylene
chloride is preferred.
The thus produced octahydro-11-naphthacenone was
then oxidized to 7alpha,9alpha- (di-O-isopropylidenyl)9beta-ethynyl-11-hydroxy-4-methoxy-7,8,9,10-tetrahy
dro-5,12-naphthacenedione. Oxidizing agents include

7
cyclohexanyl-1-yl-nitromethyl-4,4,5-trimethoxy-1oxo-1,2,3,4-tetrahydronaphthalene is complete within
4-6 days.
The thus-produced 1-oxotetrahydronaphthalene is

preferably cyclized with an alkali metal alkoxide of 1-6
carbon atoms. Suitable alkoxides can be prepared from
alkanols of 1-6 carbon atoms, as above, and an alkali
metal hydride. Alkali metal hydrides include sodium
hydride or potassium hydride, of which sodium hydride
is preferred. Most preferably, the alkali metal alkoxide

10

is sodium

CHART 4.

O

MeOOC

15

CECSiMe3
-- O

-OMe

McO

oN

o

MeO

CECH
s O

OMe

(MeO)2

o -><

(25%)

NO2

juatovo
OH

(60%)

(1) Ti(NO3)3

methods to daunosamine to produce doxorubicin and its
corresponding derivatives.
In one embodiment, the aprotic solvent for condens
ing the acetonide with 1,4-dihydro-4,4,5-trimethoxy-1oxonaphthalene is acetonitrile; the thus-produced 1
25
oxotetrahydronaphthalene is cyclized with sodium
methoxide; the thus-produced decahydro-11-naph
thacenone is converted to the octahydro-11-naphthace
none in an acidic medium; the thus-produced octahy
dro-11-naphthacenone
is oxidized to the tetrahydro
30
5,12-naphthacenedione with the thusproduced tetrahy
dro-5,12-naphthacenedione being converted to 6
desoxy-6-nitrodaunomycinone by hydrolysis and from
this compound into daunomycinone and 6 to 8
35 daunomycinones in which the substituent at C6 has been
changed.
In a further embodiment, the aprotic solvent for con
densing the acetonide with 1,4-dihydro-4,4,5-trime
thoxy-1-oxonaphthalene is acetonitrile; the thus-pro
duced 1-oxotetrahydronaphthalene is cyclized with
sodium methoxide; the thus-produced decahydro-11
naphthacenone is converted to 9beta-acetyl-4,5-dime
thoxy-6-nitro-7alpha,9alpha,12-trihydroxy
6,6a,7,8,9,10,10a, 11-octahydro-11-napthacenone by hy
45 drolysis with acid in the presence of mercuric oxide in
an acidic medium; the thus-produced 9-beta
acetylocatahydro-11-naphthacenone is oxidized to 7al
pha,9-alpha-dihydroxy-4-methoxy-6-nitro
6,6a,7,8,9,10,10a, 11-octahydro-5,11,12-naphthacenetr
ione with thallium nitrate and the produced octahydro
5,11,12-naphthacenetrione is converted to daunomyci
Os.

(2) NaOMe/MeOH
(3) TiCl3

In a preferred embodiment, 6-desoxy-6nitrodaunomycinone was converted into 6-desoxy-6-

55

daunomycinone Ti complex

methoxide. The cyclization is carried out in an inert

solvent, such as benzene, hexane or toluene.

A representative cyclic product of this condensation
is 7alpha,9alpha-(di-O-isopropylidenyl)-9beta-ethynyl
6-nitro-4,5-trimethoxy-5,5a,

decahydro-11-naphthacenone.

which

produced. These mycinones can be coupled by known

N

H

from

daunomycinone and a variety of mycinones can be

OEC
H

ione is then hydrolysed with acid in the presence of
mercuric oxide to give 6-dexosy-6-nitrodauomycinone.
The 6-nitro compound can then be reduced to 6
desoxy-6-aminodaunomycinone

-X

plume
O

cerium ammonium nitrate (CAN) and thallium trinitrate
(TTN); solvents include methanol, acetone and acetoni
trile. The preferred conditions are CAN in acetone with
dichlorodicyanobenzoquinone (DDQ) added in cata
lytic amount. The thus produced 5,-12-naphthacened

6,6a,7,8,9,10,10a, 11

The thus produced decahydro-1-naphthacenone
loses methanol in the presence of an acidic catalyst to
yield 7alpha,9alpha-(di-O-isopropylidenyl)-4,5-dime
thoxy-9beta-ethynyl-12-hydroxy-6-nitro-6,6a,7,8,
9,10,10a, 11-octahydro-11-naphthacenone. Possible cat
alysts include sulfonic acids e.g. methanesulfonic acid;

aminodaunamycinone by reduction with SnCl2.H2O in
methanol in the presence of sodium on acetate at room

temperature and the lenco product reoxidized with
The amino daunomycinone has been converted into
its diazonium compound with its amyl nitrite in dimeth
oxyethane and then acid and finally mercuric oxide was
added to form daunomycinone. A variety of other 6

cerium ammonium nitrate.

desoxy-6-substituted daunomycinones are available
from the diazonium compound.
EXAMPLES

Without further elaboration it is believed that one

skilled in the art can, using the preceding description,

5,200,513
utilize the present invention to its fullest extent. The
following preferred specific embodiments are, there
fore, to be construed as merely illustrative and not limi
tative of the remainder of the disclosure in any way
whatsoever.

In the following examples, the temperatures are set
forth uncorrected in degrees centigrade. Unless other
wise indicated, all parts and percentages are by weight.
Materials and Methods

O

1H NMR spectra were recorded on a Varian EM-390
(90 MHx), a Varian VXR-200 (200MHx) or a Nicolet
1180 WB (360 MHz) spectrometer. Data are reported as
chemical shifts in parts per million referenced to trime
thylsilane internal standard (0 ppm) or to the residual 15
chloroform peak of deuteriochloroform (7.26 ppm).
Multiplicity, number of protons and coupling constants
are reported. Couplings and/or coupling constants
were determined using the COSY technique or by pro
20
ton irradiation experiments.
13C NMR spectra were obtained on a Varian
VXR200 (50.4 MHz) spectrometer. Chemical shifts are
referenced to the center peak of the residual chloroform
triplet (77.0 ppm).
Ultraviolet spectra were obtained on a Hewlett-Pac
kard 8450 UV-Vis spectrophotometer.
Infrared absorption spectra were recorded on a Per
kin-Elmer Model 283 or an Analect RFX-30 spectro

photometer and are referenced to polystyrene (1601
cm).

Elemental analyses were carried out by Desert Ana
lytics (Tuscon, Ariz.).
,
Mass spectra were provided by the Midwest Center

25

30

for Mass Spectrometry, University of Nebraska-Lin
35
Melting points were determined in open-end capil
lary tubes on a Mel-Temp apparatus.
Column chromatography was carried out on E.
Merck silica gel 60 (Flash, 40-230 mesh) and all thin
layer chromatography (TLC) was carried out on com

coln.

10
resulting residue was dissolved in 200 mL of ice water
and acidified to pH 1 with conc HC. The resulting
solution was extracted with four 100-mL portions of
ethyl acetate. The combined ethyl acetate extracts were
washed with one 50-mL portion of saturated sodium
chloride solution, dried over sodium sulfate and evapo
rated to dryness. Crude semi-crystalline acid (24.1 g)
was washed with a small amount of cold ether to yield
5-oxocyclohex-2-ene-1-carboxylic acid, off-white crys
tals, mp 98-101 degrees centigrade, lit (Biffin et al.,
supra, 98 to 99 degrees centigrade) yield 80 to 90 per
Cent.

H NMR (CDCl3): delta values 10.0 (s, 1H, COOH),
5.9 (m, 2H, HC-CH), 3.5 (m, 1H, CHCOO), 2.8 (m,
2H, C=CCH2), 2.5 (m, 2H, CH2).
EXAMPLE 2

Methyl 5-Oxocyclohex-2-ene-1-carboxylate
A solution of 0.7M diazomethane in ether was slowly
added to a solution of 6.0 g (42.8 mmol) of 5-oxocy
clohex-2-ene-1-carboxylic acid in 100 mL of ether at 0
degrees centigrade, with swirling. The addition of di

azomethane was continued until the bubbling ceased
and a yellow color persisted. The solution was treated
with a rapid stream of nitrogen until the yellow color
was discharged. The solvent was removed by evapora
tion. Benzene (100 mL) was added and evaporated at
room temperature using an aspirator. The residue was
placed on a vacuum line for 2 hours to produce 6.5g
(42.4 mmol, 99 percent) of methyl 5-oxocyclohex-2-ene
1-carboxylate (oil).
1NNMRCDCl3): delta values 5.9 (m, 2H, HC-CH),
3.7 (s, 3H, COOMe), 3.5 (m, 1H, HCOO), 2.9 (m, 2H,
C=CCH2), 2.7 (m, 2H, CH2).
EXAMPLE 3

Methyl

cis-5-Hydroxy-5-(trimethylsilylethynyl)cyclohex

2-ene-1-lcarboxylate
mercial silica gel plates (Analtech Silica HLF 250 m or
A solution of n-butyllithium (2.5 M, 16.8 mL, 42.1
Merck Silica gel 60F 254).
High performance liquid chromatography (HPLC) mmol) was added dropwise, via a syringe, to a stirred
was performed on a Waters Associates Model 600E solution of trimethylsilylacetylene (7 mL, 46.8 mmol) in
chromatography apparatus, equipped with a Waters 45 120 mL of tetrahydrofuran (THF) at -78 degrees cen
Associates Model R403 Differential Refractometer, tigrade. The resulting slurry was stirred at -78 degrees
centigrade for 15 minutes and transferred via a cannula
using normal-phase silica gel columns.
Solvents were distilled before use over an appropriate to slurry of 13.45 g (54.6 mmol) of cerium trichloride in
drying agent under a nitrogen atmosphere. All reactions 80 mL of THF at -78 degrees centigrade. The cerium
requiring anhydrous conditions were done under nitro so chloride had been obtained by drying cerium trichlo
gen in flame-dryed flasks. Solvents were evaporated N ride heptahydrate (20.4 g, 54.6 mmol) at 140 to 160
using a Buchi rotary evaporator, then by evacuation at degrees centigrade/0.1 mm Hg for 2 hours. Nitrogen
about 0.10 mm Hg at room temperature.
was admitted to the cooled flask and 80 mL of dry THF
was added to the resulting slurry, which was stirred
EXAMPLE 1
55 overnight under nitrogen.
5-Oxocyclohex-2-ene-1-carboxylic Acid
After the addition was complete (45 minutes), the
resulting
was stirred for 1 hour at -78 degrees
The procedure of Biffin et al., Aust. J. Chem, vol. 25 centigrade.mixture
The organocerium reagent, cerium dichlo
(1972), page 1329, was used.
To a stirred slurry of 30 g (0.21 mol) of m-anisic acid ride trimethylsilylacetylide, was transferred over 45
into a solution of 6.36 g (41.3 mmol) of methyl
(3-methoxybenzoic acid) in 300 mL of liquid ammonia minutes
were slowly added small pieces of lithium (3.5 g, 0.5 5-oxocyclohex-2-ene-1-carboxylate in 80 mL of THF at
mol). Additional lithium (0.5g, 0.07 mol) was added to -78 degrees centigrade. The resulting mixture was
maintain the blue color of the solution. The mixture was stirred for 1 hour more at -78 degrees centigrade and
stirred for 2 hours and then cautiously quenched with the reaction mixture was poured without warming into
65 400 mL of 10 percent ammonium chloride solution at 0
solid ammonium chloride (45 g, 0.84 mol).
Ammonia was allowed to evaporate at room temper degrees centigrade. The resulting mixture was extracted
ature. The last traces of ammonia were removed by with four 150-mL portions of ether. The combined
warming the mixture under aspirator pressure. The organic extracts were washed with 200 mL of saturated
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aqueous sodium chloride solution and dried over so
dium sulfate. Evaporation of the solvent yielded 10.04g
(41.1 mmol, 99.5 percent) of methyl cis-5-hydroxy-5(trimethylsilylethynyl)cyclohex-2-ene-1-carboxylate,
an oil.

IR(CH2Cl2): 3585 (COH), 2160 (CEC), 1721

(COOCH3), 1653 (CEC) cm-l.
NRMCDCl3): delta values 5.9-5.7 (n, 2H,
CH=CH), 3.7 (s, 3H, COOCH3), 3.3 (m, 1H, CHCOO),
2.6 (s, H, OH), 2.5 (dd, 1H, C-CCH2), 2.4 (dd, H,
C-CCH2), 2.2 (m, 2H, CH2), 0.2 (s, 9H, Si(CH3)3).

13C NMR CDCl3): delta values 174.0, 125.3, 1234,
MS, m/e (relative intensity): 252.21166 Mt (0.72),
237,0949 M-CH3+ (29), 140,0657 (61). HRMS calcd

O

108.2, 87.4, 65.7, 51.9, 41.2, 39.1, 37.6.

for Cl3H20O3Si: 252.1181.
Anal. Calcd for C13H20O3Si: C, 61.86, H, 7.99.
Found: C, 62.10, H, 8.13,

15

12
silylethynyl)cyclohex-1-ene-1-carboxylate, a colorless
oil, which crystallized on standing, mp 89.8 to 90.8
degrees centigrade.
IR (CH2Cl2): 3310 (OH, 2658 (C-C), 1721
(COOCH3), 1653 cm-1.
iH NMR CDCl3): delta values 7.1 (s, 1H, CCH), 4.4
(m, all couplings less than 2 Hz, 1H, CCHOH)), 3.8 (s,
3H, COOCH3), 3.0-3.4 (m, H, OH), 2.9-2.8 (dd, 2H,
CH2), 2.6 (s, 1H, OH), 2.5-2.2 (dd, 2H, CH2), 0.17 (s,
9H, C-CSi(CH3)3).
1H NMR (D6DMSO): delta values 7.1 (s, 1H,
C=CH), 6.2 (2,1H, OH), 5.6 (d, 1H, OH), 4.7 (bs, 1H,
CCHOH)), 4.0 (s, 3H, COOCH3), 3.0 (d, Jai 7 Hz, 1H,
C=CCH equatorial), 2.6 (d, J =17 Hz, 1H, C=CCH
axial), 2.5 (n, 1H, (HOCCH axial), 1.9 (dd, J-10, 10
Hz, 1H (HO)CCH axial).

13C NMR CDCl3): 167.20 (C=O), 138.88, 127.60,

Methyl

108.0, 88.52, 66.04, 61.62, 51.92, 41.74, 38.87, 0.228.
Anal. Calcd for C13H20O4Si: C, 58.18; H, 7.51.
Found: C, 58.24; H, 7.65.

clohexane-1-carboxylate

EXAMPLE 6

EXAMPLE 4

cis-(2,3-Epoxy-5-hydroxy)-5-(trimethylsilylethynyl)cy
A solution of tert-butyl hydroperoxide (4.1 M, 0.85
mL, 3.4 mmol) in isooctane was added to a stirred mix
ture of molybdenum hexacarbonyl (10 mg, 0.07 mmol)
and 0.1753 g (0.6946 mmol) of methyl cis-5-hydroxy-5(trimethylsilylethynyl)cyclohex-2-ene-1-carboxylate in

25

10 mL of benzene. The mixture was then heated under
reflux for 2 hours. The mixture cooled and was washed 30

with three 10-mL portions of water. The combined
aqueous layers were extracted with three 5-mL portions
of methylene chloride and dried over sodium sulfate.
Evaporation of the solvent gave 0.1805 g (97 percent) of
an oil. Flash chromatography of the oil (4:1 hexanes 35
Methyl acetate v?v) gave crystalline methyl cis-(2,3epoxy-5-hydroxy)-5-(trimethylsilylethynyl)cyclohex
ane-1-carboxylate (0:131 g, 70 percent), mp. 74.1 to 74.6
degrees centigrade.
IR(KBr): 3360 (OH), 2160 (C=C), 1732 (C=O),
1260, 845 cm-l.
1H NMR CDCl3) 3.8 (s, 3H, COOCH3), 3.5 (m, H,
CHCOO), 3.3 (m, 2H, HCOCH), 2.4 (dd, 1H, CH2), 2.3
(s, H, OH), 2.0 (d, 1, CH2), 1.85 (m, 2H, CH2), 0.17
45
(s, 9H, CsCSi(CH3)3).
13C NMR CDCl3) 172.45 (COO), 107.43 (SiCEC),
89.47 (CsC), 66.26, 52.2, 51.80, 50.71, 40.92, 38.26,
31.03, 0.20 (Si(CH3)3).
MS m/r (relative intensity): 253.0897 (21.8) M
CH3+, 236,0871 (38.2) M-CH3OH)+, 191.0035 (19.3),
159,0715 (16.6). Calcd for C13H20OSi: 253.0896.
Anal. Calcd for C13H2O4Si: C, 58,18, H, 7.51. Found:
C, 58.09, H, 7.65.
EXAMPLES

Methyl

cis-3,5-Dihydroxy-5-(trimethylsilylethynyl)cyclohex

1-ene-1-carboxylate.

A solution of 92.8 mg (0.345 mmol) of methyl cis-(2,3epoxy-5-hydroxy)-5-(trimethylsilylethynyl)cyclohex
ane-1-carboxylate and 52.5 mg (0.345 mmol) of 1,8diazabicylo-5.4.0-undec-7-ene in 10 mL of methylene
chloride was stirred for 2 hours at room temperature.
The solvent was removed by evaporation and the resi
due was dissolved in a minimum amount of methylene
chloride and filtered through a plug of flash silica gel
. (1:1 hexanes/ethyl acetate v/v). Evaporation of the

solvent yielded methyl cis-3,5-dihydroxy-5-(trimethyl

55

Addition of Nitromethane to Methyl
cis-3,5-Dihydroxy-5-(trimethylsilylethynyl)cyclohex
1-ene-1-carboxylate
(i) Methyl cis-3,5-dihydroxy-5-trimethylsilylethynyl
cyclohex-1-ene-1-carboxylate (5.91 g, 22.0 mmol) was
added in one portion to a mixture of nitromethane (12.2
g, 44.0 mmol) and DBU (6.7g, 22.0 mmol) in 30 mL of
dimethyl sulfoxide (DMSO). The mixture was stirred at
room temperature for 15 hours and then neutralized to
pH 6 with about 20 mL of 6 M HCl.
The resulting mixture was extracted with four 100
mL portions of ethyl acetate. The organic phase was
washed with 30 mL of saturated aqueous sodium chlo
ride solution and dried over sodium sulfate. Evapora

tion of the solvent gave a crude oil product (10.0 g),
which contained some DMSO.
m
Flash chromatography in ethyl acetate/hexanes (3:7

v/v) gave methyl 3alpha,5alpha-dihydroxy-5beta
(trimethylsilylethynyl)-2alpha-nitromethylecyclohex
ane-1-beta-1-carboxylate (trans isomer, 0.8321g, 2.5
mmol, 11.5 percent); methyl 3alpha,5alpha-dihydroxy
5beta-trimethylsilylethynyl-2beta-nitromethylcy

clohexane-2beta-carboxylate (the cis isomer, 1.95 g, 5.9
mmol, 26.9 percent); methyl 3alpha, 5alpha-dihydroxy
5beta-ethynyl-2alpha-nitromethylcyclohexane-1beta
carboxylate (trans desilylated isomer, 1.52 g. 5.9 mmol,
26.9 percent); methyl 3alpha,5alpha-dihydroxy-5beta
ethynyl-2beta-nitromethylcyclohexane-1beta-carboxy
late (cis desilylated isomer, 1.28, 5.0 mmol, 22 percent).
The overall yield of nitro adducts was 88 percent.
(ii) Nitromethane (8 mL, 112 mmol) was added to a
slurry of sodium hydride (2.4g, 56 mmol, 50 percent in
mineral oil) in 50 mL of dry DMSO. The mixture was
cooled as necessary to maintain an internal temperature
of 20 degrees centigrade and stirred slowly for 1 hour.
Methyl c is-3,5-dihydroxy-5-(trimethylsilylethynyl)cylohex-1-ene-1-carboxylate (3.0 g. 11.2 mmol) was
added in one portion and the mixture was stirred for 24
hours at room temperature. To the resulting mixture
was added 3 mL of conc HCl in ice. Additional HC1

was added until the pH reached 7. The mixture was
extracted with four 150-mL portions of ether, washed
with 100 mL of saturated aqueous sodium chloride
solution, dried over sodium sulfate and evaporated to
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1beta-carboxylate (0.25 g, 12.4 percent, trans desilylated
isomer) and methyl 3alpha, 5alpha-dihydroxy-5beta

13
give 3.39 g of residue, which contained some DMSO
(TLC).
Flash chromatography in ethyl acetate/hexanes (3:7
v/v) gave 2.12 g of product, characterized as a mixture

ethynyl-2beta-nitromethylcyclohexane-2beta-carboxy
late (0.19 g, 9.4 percent, cis desilylated isomer).

of diastereomeric methyl 3,5-dihydroxy-5-(trimethyl
silylethynyl)-2-nitromethylcyclohexane-1-beta-car
boxylates.
Trans isomer (1.021 g, 25.8 percent), methyl 3alpha,
5alpha-dihydroxy-5beta-(trimethylsilylethynyl)- 2al

pha-nitromethylcyclohexane-1betacarboxylate:
IR (CH2Cl2): 3421, 2958, 2161, 1737, 1558 cm-1.
1H NMR CDCl3): delta values 4.7-4.6 (dd, 1H,

CH2NO2), 4.0-4.1 (m, 1H, CHOH), 3.8 (bs, 2H, OH),
3.7 (s, 3H, COOCH3), 2.8-2.9 (ddd, J =4, 12, 12 Hz,
CHCOOCH3) 2.5-2.6 (m, 1H, CHCH2NO2), 2.3-2.4
(m, 2H, CH2 equatorial), 2.0 (dd, J =12, 12 Hz, 1H,

CH2 axial), 1.9 (dd, J =12, 3 Hz, lh, CH2 axial), 0.1 (s,
9H, Si(CH3)3).
13C NMR (CDCl3): delta values 173, 128, 106, 87,75,
67.1, 66.8, 52, 41.5, 41.2, 36.7, 0.3.
Cis isomer (1.101 g, 19.8 percent), methyl 3alpha,5al
pha-dihydroxy-5beta-(trimethylsilylethynyl)-2beta
nitromethylcyclohexane-1betacarboxylate:
IR (CH2Cl2) 3423, 2956,2160, 1739, 1556 cm-1.
1H NMR CDCl3): delta values 4.6 (dd, 1H,
CH2NO2), 4.1 (m, 1H, CHOH), 3.7 (s, 3H, COOCH3),
2.9 (bs, 2H, OH), 2.0-2.2 (nc, 4H, CH2), 0.2 (s, 9H,
Si(CH3)3).
13C NMR: delta values 173, 128, 106, 89, 74, 67.7,
67.1, 52, 41, 37, 30, 0.2.
Anal. Calcd for C14H22O6NSi: C, 51.20, H. 6.75, N,
4.26. Found: C, 51.20; H, 7.19: N, 4.17.

EXAMPLE 8

O

15

20

solution was cooled and washed with 30 mL of satu

rated aqueous sodium bicarbonate solution with 30 mL.

25

30

EXAMPLE 7

Addition of Nitromethane to Methyl
cis-(2,3-Epoxy-5-hydroxy)-5-(trimethylsilylethynyl)cy
clohexane-1-carboxylate
Nitromethane (4.2g, 68 mmol) was added to a solu
tion of 50 mL of DMSO and 5.2 g (34 mmol) of DBU
in 50 mL of DMSO. The mixture was stirred for 5
minutes, after which 1.8 g (6.8 mmol) of solid methyl
cis-2,3-epoxy-5-hydroxy-5-(trimethylsilylethynyl)cy
clohexane-1-carboxylate was added in one portion. The
reaction was followed by TLC, using 1:2 v/v ethyl
acetate/hexanes as eluant. After 2 hours, all of the epox
ide had been consumed and a new spot, corresponding

Acetonide of Methyl 3alpha,5alpha-Dihydroxy-5
beta-(trimethylsilylethynyl)-2alpha-nitromethylcy
clohexane-1beta-carboxyate
A mixture of 2-methoxypropene (260 microL, 3.6
mmol), trans nitro diol (methyl 3alpha,5alphadihy
droxy- 5beta-(trimethylsilylethynyl)-2alpha-nitrome
thylcyclohexane-1beta-carboxylate, 1.2 g, 3.6 mmol)
and pyridinium tosylate (10 mg, 0.036 mmol) in 100 mL
of benzene was stirred for at room temperature for 15
minutes. After 260 microL (3.6 mmol) of additional
2-methoxypropene was added, the resulting mixture
was heated under reflux for 5 minutes. The resulting

35

of saturated aqueous sodium chloride solution and dried
over sodium sulfate. Evaporation of solvent yielded
1.22 g (3.22 mmol, 89 percent) of acetonide as an oil.
R (neat ATR): 2990, 2164, 1735, 1556 cm-l.
1H NMR CDCl3) delta values 4.6-4.5 (dd, 1H,

CHNO2), 4.44.35 (dd, 1H, CHNO2), 4.25-4.3 (m, 1H,
CHOC), 3.7 (s, 3H, COOCH3), 3.0 (ddd, J =3, 4, 15 Hz,
1H, CH equatorial), 2.85 (ddd, J =5, 12, 12 Hz, 1H,
CHCOOCH2), 2.6 (m, 1H, CHCH2NO2), 2.4 (ddd, J
=3, 5, 15 Hz, 1H, CH equatorial), 1.8 (m, 2H, CH axi
als), 1.6 (s, 3H, CH3), 1.4 (s, 3H, CH3), 0.16 (s, 9H,

Si(CH3)3).
13C NMR CDCl3): delta values 1736, 106.3, 97.9,

88.5, 75.2, 66.3, 65.4, 52.0, 41.8, 41.5, 38.7, 33.0, 31.4,

30.3, 0.3.

HRMS, m/e (relative intensity): 354.1366 (M-CH3)+
(11 3), 294.1158 (M-OC3 H6+ (5.4), 264. 1184 (294
NO2+ (46.5), 73.0472 TMSi)+ (100); calcd for
C6H24NO 6Si 354.1373.

EXAMPLE 9
45

Oxidation of 1-hydroxy-5-methoxy-naphthalene to
1,4-dihydro-4,4,5-trimethoxy-1-oxonaphthalene by
Iodobenzene Diacetate

to diol appeared. After 16 hours, TLC showed that four
of 15.5g (48 mmol) of iodobenzene diace
new products and no starting materials or diol was tateA solution
and
22g
of NaHC3 in 100 mL of methanol/present.
trimethyl orthoformate (1/1) was stirred at room tem
The reaction mixture was poured into 100 mL of cold
for 30 minutes. To this mixture a solution of
5 percent HCl solution and extracted with four 50-mL perature
3.74g
of
1-hydroxy-5-methoxynaphthalene
mmol)
portions of water and with 100-mL of saturated aqueous in 250 mL of methanol was added dropwise.(21.5
The
color
NaCl solution and dried over sodium sulfate. The ether
the mixture changed from orange to greenish yellow
was evaporated to yield 0.66 g of an oil, which was of
at room temperature.
separated by flash chromatography (1:2 v/v ethyl 55 over 2 hours
(150 mL) was added to the mixture, and then
acetate/hexanes) to yield methyl 3alpha, 5alpha-dihy sat.Ether
NaHCO3 (75 mL). The aqueous washings were
droxy-5beta-(trimethylsilylethynyl)-2 alpha-nitrome
thylcyclohexane-1beta-carboxylate (0.28 g, 12.5 per back extracted with ether (75 mLX3). The combined
extracts were washed with saturated aqueous
cent, trans nitro diol) and methyl 3alpha,5alpha-dihy ethereal
sodium chloride solution and dried over sodium sulfate.
droxy-5beta-(trimethylsilylethynyl)-2beta-nitromethyl The
solution was evaporated to give 1,4-dihydro-4,4,5cyclohexane-1beta-carboxylate (0.31 g, 13.8 percent, cis trimethoxy-1-oxonaphthalene.
nitro diol).
Flash chromatography of this product with elation
The aqueous phase was reextracted with methylene
chloride and dried over sodium sulfate. Evaporation of using EtOAc:Hex 1:1 yielded 3.70g (74 percent) of
solvent gave 0.52g of an oil, separated by flash chroma 65 crystals of 1,4-dihydro-4,4,5-trimethoxy-1-oxonaphtha
tography (1:l v/v ethyl acetate/hexanes) into two lene, mp. 62-63 degrees centigrade.
desilylated nitroadducts, methyl 3alpha,5alpha-dihy
H NMR (CDCl3): delta values 7.7 (d, 1H, aromatic),
droxy-5beta-ethynyl-2alphanitromethylcyclohexane
7.52 (t, 1H, aromatic), 7.16 (d, 1H, aromatic), 6.80 (m,
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phase was further washed with 5 mL of saturated aque
ous sodium bicarbonate solution, with two 10-mL por
tions of saturated aqueous sodium chloride solution and
dried over sodium sulfate. The solvent was evaporated
5 to give 0.372 g of crude oily product, which was flash
1031 cm-l.
chromatographed (30:70 v/v ethyl acetate/hexanes,
EXAMPLE 10
50:50 ethyl acetate/hexanes) to yield 0.212 g (0.42
3-(2beta-Carbomethoxy-4-beta-ethynyl-4-alpha-6alpha then
mmol, 59.8 percent) of 9beta-ethynyl-5,5-dimethoxy-12
(di-O-isopropylidenyl)-cyclohexanyl-1-yl)nitromethyl hydroxy-7alpha,9alpha-(di-O-isopropylidenyl)-44,4,5-trimethoxy-1-oxo-1,2,3,4-tetrahydronaphthalene O methoxy-6-nitro-5,5a,6,6a,7,8,9,10,10a, li-decahydro
A solution of 0.904 g (3.0 mmol) of trans nitroaceto 11-naphthacenone, white crystalline solid, mp 234 de
nide (acetonide of methyl 3alpha, 5alpha-dihydroxy grees centigrade (decomp).
5beta-(trimethylsilylethynyl)-2alpha-nitromethylcy
IR (ATR thin film): 3320 (C=C-OH), 2260 (CECH),
clohexane-1beta-carboxylate), 1.34 g (5.7 mmol) of 1.4- 1559 (NO2) cm-1.
dihydro-4,4,5-trimethoxy-1-oxonaphthalene and 750 15 1H NMR (CDCl3): delta values 16.2 (s, 1H,
microL (5 mmol) of DBU in 0.5 mL of acetonitrile was
7.8 (d, H, ArH), 7.1 (d, 1H, ArH), 5.2 (dd,
stirred for 5 days at room temperature. Methylene chlo JC-COH),
=1, 3 Hz, 1H, CHNO2), 4.6 (d, J =4.5 Hz, 1H,
ride (5 mL) was added to the mixture and the solution CHOC), 3.9 (s, 3H, ArOCH3), 3.9 (ddd, J = 4.5, 13, 13
was chromatographed on a column packed with 150 g Hz, 1H, 0-CCH), 3.5 (d, J =4.5Hz, 1H, C=C-CHC
of silica gel (5 cm column, 30:70 v/v ethyl acetate/hex 20 HNO2),
3.4 (s, 3H, OCH3 ketal), 3.1 (ddd, 1H, CH2
anes slurry). The material on the column was eluted equatorial),
3.0 (s, 3H, OCH3 ketal), 2.9 (ddd, J =3, 3,
with 400 mL of 30:70 v/v ethyl acetate/hexanes. After 13 Hz, 1H, CH2
equatorial), 2.5 (s, 1H, CsCH), 1.8 (d,
the nitro acetonide was eluted, as followed by TLC J=12
Hz, 1H, NO2CHCHCO), 1.67 (d, 1H, CH2 axial),
(iodine development), the chromatographic separation
was continued with 1000 mL of 50:50 v/v ethyl aceta 25 1.64 (s, 3H, OCCH3), 1.5 (dd, J =12, 12 Hz, 1H, CH2
axial), 1.3 (s, 3H, OCCH3).
te/hexanes.

15
2H, HC-CH), 3.92 (s, 3H,OCH3), 3.14 (s, 6H,
(OCH3)2) (2 OCH3).
UV (MeOH): maximum wavelength; 222 nm.
IR (neat): 1672, 1635, 1589, 1580, 1300, 1178, 1068,

13C NMR (CDCl3): HETCOR-DEPT 196.9 (C-O),

Evaporation of the solvent from the various fractions
gave recovered nitro acetonide (0.66 g, 2.2 mmol), re
covered dimethyl ketal (1.03 g, 4.4 mmol) and product,

3-((2beta-carbomethoxy-4-beta-ethynyl-4-alpha,6alpha
(di-O-isopropylidenyl)cyclohexanyl-1-yl)-nitromethyl
4,4,5-trimethoxy-1-oxo-1,2,3,4-tetrahydronaphthalene

(0.274 g, 0.51 mmol, 62 percent based on recovered
acetonide) as an oily mixture of diasteromers.
IR (ATR thin film): 1733 (COOMe), 1686 (C=O),
1588, 1579 (NO2) cm-1.
1H NMR (CDCl3): delta values 7.6 (d, 1H, Ar), 7.4

(dd, 1H, Ar), 7.1 (d, 1H, Ar), 5.3-5.0 (d, 1H, CHNO2),
44-4.0 (m, 1H, CHOC), 3.7 (s, 3H, Ar0CH3), 3.5 (s,
3H, COOCH3), 3.3-2.8 (complex group of overlapping
protons, 10H), including (COCH3 ketal, 3.2, 3H, and
3.1, 3H), (O-CCH2, 2H), and (CHCOOCH3, 1H),
(HCCHNO2, 1H)), 2.5 (s, 1H, C=CH), 2.5 (d, iH,
CH2), 2.2 (d, 1H, CH2), 1.8 (d, 1H, NO2CHCH), 1.6-1.5
(m, 2H, CH2, 1.5 (s, 3H, CCH3), 1.2 (s, 3H, CCH3).
13C NMR (CDCl3): mixture of two distereomers,
(195.4, 195.1), (174.3, 173.2), (157.6, 157.5), (134.3,
134.0), (130.3, 1302), (125.3), (120.05, 1200), (117.2,
117.15), (101.6, 101.6), (97.9, 97.7), (86.1, 85.10), (84.48,
84.42), (72.6, 72.5), (66.0, 65.9) (64.5, 64.4), (55.9), (52.2,
51.6), (50.56, 50.46), (50,4, 50.1), (43.443.1), (42.8, 42.7),
(42.0, 40.7), (39.77, 39.70), (35.8, 35.6), (32.7, 32.6), (31.2,
31.1), (30.05, 29.9).
EXAMPLE 11

9beta-Ethynyl-5,5-dimethoxy-12-hydroxy-7alpha,
9alpha-di-O-isopropylidenyl)-4-methoxy-6-nitro-5,
5a,6,6a,7,8,9,10,10a-decahydro-11-naphthacenone
Sodium hydride (64 mg, 1.4 mmol) was added in one

portion to a solution of 3-[(2beta-carbomethoxy-4-beta
ethynyl-4-alpha,6alpha-(di-O-isopropylidenyl)cyclohex
anyl-1-yl)-nitromethyl-4,4,5-trimethoxy-1-oxo-1,2,3,4tetrahydronaphthalene (0.377 g, 0.7 mml) and methanol
(80 drops) in 25 mL of toluene at 0 degrees centigrade.

After 15 minutes' stirring, the cooling bath was re
moved. The reaction mixture was stirred for an addi

tional 4 hours at room temperature and then washed
briefly with 10 mL of cold 5 percent HCl. The organic
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172.6 (ArC=COH), 157.2 (ArC=COH), 133.0 (Ar),
130.6 (ArH), 122.8 (Ar), 119.4 (ArH), 115.7 (ArH),
101.6, 101.3, 98.4, 85.2 (CECH), 79.9, 72.1 (CHNO2),
69.5 (CHOC), 66.3, 55.8 (ArOCH3), 52.5 (COCH3), 51.4
(COCH3), 46.0 (NO2CCHCO), 44.8 (CHCNO), 402
(CH2), 35.3 (CHC-O), 34.3 (CH2), 30.8 (OCCH3), 30.4
(OCCH3).
UV-Vis: maximum wavelengths: 346, 341,230 nm.
EXAMPLE 12

9beta-Acetyl-7alpha,9alpha, 12-trihydroxy-4,5-dime
thoxy-6-nitro-6,6a,7,8,9,10,10a, 11-octahydro-1lnaph
thacenone

Sulfuric acid (1.5 mL, 3M) was added to a solution of
212 mg (0.42 mmol) of 9beta-ethynyl-5,5-dimethoxy-12

hydroxy-7alpha,9alpha-(di-O-isopropylidenyl)-4-

45

methoxy-6-nitro-5,5a,6,6a,7,8,9, 10,10a,11-decahydro
11-naphthacenone in 20 mL of THF. The solution im
mediately turned a bright yellow color. To the resulting
solution was added 24.5 mg (0.11 mmol) of HgO. The
resulting mixture was stirred for 4 hours at room tem

55

perature, cooled to 0 degrees centigrade and neutralized
to pH 6 with 0.5g of potassium hydroxide in 3 mL of
water. The mixture was poured into 20 mL of water and
extracted with four 20-mL portions of ethyl acetate.
The combined organic layers were washed with two
20-mL portions of water and with 20 mL of saturated
aqueous sodium chloride solution and dried over so

dium sulfate. The solvent was removed by evaporation
to yield 0.176 g (0.39 mmol, 93.2 percent) of 9beta-acet
yl-7alpha,9alpha, 12-trihydroxy-4,5-dimethoxy-6-nitro
6,6a,7,8,9,10,10a, 11-octahydro-11-naphthacenone, yel
low solid. Product recrystallized from acetone gave fine
yellow needle crystals, mp 186 degrees centigrade (de
comp).
IR (ATR thin film): 3427 (OH), 1711 (C-O), 1628,
65 1591, 1554 (NO2) cm1.
H NMR (THF D4): delta values 14.3 (s, 0.5H,
AroH), 8.0 (d, 1H, ArH), 7.5 (dd, 1H, ArH), 7.2 (d, 1H,
ArH),m 6.4 (d, 1H, CHNO2), 5.5 (bs, 0.5H, OH), 5.0 (bs,
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rated by chromatography. Major isomer 85 percent
m.p. 243-244 degrees centigrade.
IR (KBr) 3262, 1733, 1616, 1572, 1563, 1554, 1501,
1456, 1430, 1382, 1276, 1261, 1215 cm-l.
NMR (360 MHz, CDCl3): major isomer 14.01(s, 1H),
8.12(d, 1H), 7.49(t, 1H), 7.72(d, 1H), 6.35(d, J =4
13C NMR (THF D4): delta values 211.3 (C-O), . H2H), 4.73(d, 1H), 3.95(s, 3H), 3.27(m, 1H), 2.16(d,
206.7 (C=O), 160,0, 157.3, 128.5, 122.4, 117.6, 117.5, 1H), 1.61(s, 3H), 1.30s, 3H), ppm.; (minor isomer 15
112.5, 112.4, 10.1, 81.9, 80.4, 69.87, 69.83, 62.7, 56.6, percent) 13.34(s, 1H), 8.05(d, H), 7.47(t, 1H), 7.05(d,
O
46.0, 39.1, 36.2, 35.9, 35.8.
1H), 6.21(d, J 104 H2lH), 4.40(d, 1H), 3.91 (s, 3H),
UV-Vis (MeOH) maximum wavelengths: 339, 321, 3.71(s,
3H), 3.66(d, H), 3.12(m, 2H), 2.53(s, 1H),
262,220 nm.
2.19(m, 2H), 1.67(s, 3H), 1.37(s, 3H) ppm.
EXAMPLE 13
UVVisi (MeOH) maximum wavelength: 230, 266,
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0.5H, OH), 4.6 (m, 1H, CHOH), 3.9 (s, 2H, ArCCH3
D-ring), 3.7 (s, 3H, Ar0CH3 C-ring), 3.7 (ddd, 1H,
COCH), 2.6 (ddd, H, CH2 equatorial), 2.5 (ddd, 1H,
CH2 equatorial), 2.3 (s, 3H, COCH3), 1.8 (m, 1H,
NO2CHCH), 1.8-1.7 (m, 2H, CH2 axials partly ob
scured by THF peak).

9beta-Acetyl-7alpha,9alpha-dihydroxy-4-methoxy-6nitro-5,6,6a,7,8,9,10,10a,11,12-decahydro-5,11-12-naph
thacenetrione

Thallium nitrate (55 mg, 0.11 mmol) was added to a

15

328, 396 mm.
Anal. Calcd. for C25H5ON: C, 64.2, H, 5.39, N,
3.00. Found: C, 64.9, H, 5.31, N: 3.04.
EXAMPLE 5

solution 50 mg (0.11 mmol) of 9beta-acetyl-7alpha,9al
pha,12-trihydroxy-4,5-dimethoxy-6-nitro-6,6a,7,8,9,10,- 20 7alpha-9alpha-(Di-O-isopropylidenyl)-9beta-ethynyl
11-hydroxy-4-methoxy-6-nitro-7,8,9,10-tetrahydro-5,
10a, 11-octahydro-11-naphthacenone in 5 mL of acetone
12-nathacenedione

at 0 degrees centigrade. The mixture was brought to

room temperature and stirred for 2 hours. Additional
A solution of 36 mg (0.075 mmol) of the octahydro
thallium trinitrate (11 mg, 0.02 mmol) was added and 25 11-naphthacenone and 60 mg (0.675 mmol) of NaHCP3
stirring was continued for 1 hour. The resulting solution in 10 mL of acetone was treated with a solution of 167
was poured into 20 mL of water and extracted with mg (3mmol) of cerium ammonium nitrate (CAN) and 1
three 25-mL portions of ethyl acetate. The combined mg of dichlorodicyanobenzoquinone (DDQ) in 2 mL of
organic extracts were washed with two 25mL portions acetone added in one portion at 0 degrees centigrade.
of water and with 25 mL of saturated aqueous sodium The reaction mixture was stirred at room temperature
chloride solution and dried over sodium sulfate. The 30
1.5 hours during which the color changed from
solvent was evaporated to yield 99.5 mg of crude yel for
shiny
yellow to orange red, and then 25 mL of CH2Cl2
low product, an orange solid.
was
added.
The mixture was filtered through over Cel
The product, which turned black upon standing, was
The organic layer was washed with saturated NaCl
dissolved in 5 mL of 9:1 ethyl acetate/hexanes v/v. ite.
solution (2X20 mL), dried over Na2SO4, and evapo
After 16 hours, an orange precipitate had formed. The 35 rated
to give the tetrahydro-5,12-naphthacenedione as a
supernatant was removed by decantation and the result red crystals
(29 mg, 86 percent).mp greater than 258
ing solids dried to give 25 mg (0.06 mmol, 54.5 percent) degrees centigrade
(decomp).
of 9beta-acetyl-7alpha,9alpha-dihydroxy-4-methoxy-6IR (KBr) 3306, 1620, 1588, 1529, 1491, 1369 cm-.
nitro-5,6,6a,7,8,9,10,10a,11,12-decahydro-5,11,12-naph
1H NMR (360 MHz, CD2Cl21soo(s, 1H), 7.57(t, 1H),
thacenetrione, mp 242 degrees centigrade (decomp).
1H NMR (acetone D6): delta values 7.9 (dd, lh, aro 7.36(d, 1H), 4.50(m, 1H), 4.00(s, 3H), 3.12(m, 2H),
matic), 7.7 (d, 1H, aromatic), 7.6 (d, 1H, aromatic), 6.2 2.65(m, 2H), 2.57(s, 1H), 1.68(s, 3H), 1.37(s, 3H) ppm.
UV-Vis. (MeOH) maximum wavelength: 223, 240,
(d, J=4.5Hz, 1H, CHNO2), 5.5 (s, 0.5, OH), 4.9 (m,0.5,
OH), 4.7 (m. 1H, CHOH), 4.0 (s, 3H, ArOCH3), 3.5 248, 358, 440 nm; (CHCl3). 246, 370, 390, 416, 436 mm.
(ddd, J =4, 12, 13, Hz, 1H, COCHCH2), 2.8 (ddd, J =l, 45
EXAMPLE 16
5, 13 Hz, 1H, COCHCH2 equatorial), 2.4 (ddd, 1H,
6-Desoxy-6-nitrodaunomycinone
COHCH2 equatorial), 2.3 (s, 3H, COCH3), 1.9 (m, 1H,
NO2CHCH partially obscured by acetone quintet).
A solution of 12 mg of (0.027 mmol) of the tetrahy
IR (ATR thin film): 1709 (C=O), 1663, 1665, 1587, dro-5,12-naphthacenedione
in 2.5 mL of tetrahydrofu
1560 (NO2) cm-l.
ran
was
treated
with
150
microL
of H2SO4(3M) and
UV-Vis (MeOH) maximum wavelengths: 424 nm. then 5 mg of mercuric oxide at 0 degrees
centigrade and
274, 258 nm.
stirred at room temperature for 24 hours. The turbit
EXAMPLE 14
solution was neutralized with NaHCO3 to pH 8, and
7alpha,9alpha-(Di-O-isopropylidenyl)-4,5-dimethoxy 55 extracted with CH2Cl2 (10X) 15 mL). The extract was
dried over Na2SO4, and evaporated to yield 6-desoxy-69beta-ethynyl-12-hydroxy-6-nitro-6,6a,7,8,9,10,10a,
nitrodaunomycinone as a red solid (7 mg, 61.4 percent)
11-octahydro-11-naphthacenone
. Flash chromatography on silica (60-200 mesh) eluting
A catalytic amount of pyridinium tosylate (5 mg) was with
70:25:5(ethyl acetate:hexane:MeOH) afforded 2
added to a solution of 100 mg (0-20 mmol) of the
the pure mycinone as red crystals. .
decahydro-11-naphthacenone (example 11) in 20 mL of 60 ngIRof(CHC13),
3364, 1708, 1662, 1615, 1591, 1525, 1499,
CH2Cl2. The mixture was refluxed for 6 hours while the
color of the solution changed from light to shiny yel 1446, 1278, 1336 cm.
1H NMR (360) MHz, CD2Cl2 15.15(s, 1H), 8.06 (d,
low. The reaction mixture was washed with water
1H), 7.820t, 1H), 7.42(d, 1H), 5.44(m, 1H, OH), 4.61(s,
(2x20 mL) dried over Na2SO4 and the solvent was 65 1H),
4.09(s, 3H), 3.79(m, 1H, OH), 3.21(d, 1H), 3.00(d,
removed in vacuo. The yellow residue was recrystal
lized from hexane: ethyl acetate (9:1) to give the octahy 1H), 2.40(s, 3H), 2.30(d, 1H), 2.21(m, 1H) ppm.
UVVisi maximum wavelengths: (CHC13) 245, 250,
dro-11-naphthacenone as a mixture of 2 stereoisomers at
C6 (88 mg, yield 94 percent). The isomer can be sepa 420, 446 nm; (MeOH)360, 385, 418, 441, 466 mm.
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EXAMPLE 17

6-Amino-9beta-ethynyl-4-methoxy-7alpha,9alpha,11
trihydroxy-7,8,9,10-tetrahydro-5,12-naphthacenedione

20

zation from CHCl3 gave 3 mg of daunomycinone (mp
217-221 degrees centigrade).

w

1H-NMR (CD2Cl2, 360 MHz), 14.22 (s , 1H),
13.47(2,1H), 8.21 (d.1H), 8.00 (t, 1H), 7.61 (d.1H), 5.48
A solution of 15 mg (0.033 mmol) of 6-desoxy-6- 5 (m, 1H), 4.23 (s.3H), 4.07 (s.3H), 3.95 (d, 1H), 3.10
nitrodaunomycinone and 96 mg (0.70 mmol) of (m,2H), 2.57 (s.3H), 2.30 (m,2H) ppm.
NaOOCCH3:3H2O in 2 mL of CH3OH was treated

with SnCl2.H2O (183 mg, 0.88 mmol), in 3 portions over
a 90 min. at room temperature. During the addition the

FT-IR (CH2Cl2) 3540, 3053, 2927, 1712, 1616, 1578,

1420 cm-l.

UV-Visi (MeOH) maximum wavelength: 532, 495,

color of the solution changed to yellow. After the 10 476,287, 253,234mm.

The preceding examples can be repeated with similar
SnCl2 was added, the mixture was stirred for 1 h, and
the solvent was evaporated. A mixture of 15ml of success by substituting the generically or specifically
CH2Cl2 and 15mL of saturated aqueous NaHCO3 was described reactants and/or operating conditions of this
added and the mixture was stirred for 30 min. During invention for those used in the preceding examples.
the stirring the color changed to pink and CO2 was 5 Although preferred embodiments of the invention
evolved.
have been described with some particularity, many
The mixture was filled through Celite and extracted modifications
and variations in the preferred embodi
with CH2Cl2(3x20mL). The combined organic layers ment are possible
deviating from the invention.
were washed with saturated aqueous NaCl, dried (Na2 20 Is it therefore to bewithout
understood
that, within the scope of
SO4), and evaporated to yield 14 mg of yellow solid. the appended claims, the invention
may be practiced
TLC showed that this was a mixture of 2 compounds. other
than
as
specifically
described.
Flash chromatography using elution with hexane: ethyl
What is claimed is:
aceate; MeOH(75:20:5) gave two compounds, the 6
1. A process for the production of a compound of the
desoxy-6-nitro starting material (6mg), and 6-amino
9beta-ethynyl-4-methoxy-5,7alpha,9alpha,11,12-pen 25 general formula:
tahydroxy-7,8,9,10-tetrahydronaphthacene (7.5mg) as
shining yellow crystals (mp, 234-238 degrees centi
grade).
NMR: 14.1(s, 1H,OH)0), 13.4(s.2H,OH),8.1(d.1H),
7.7(t, 1H),7.2(d, 1H),5.0(n, 1H)4.25(m, 1H,OH),404(s, 30
3H),3.62(m,2H,NH2),3.15(mlH,OH),2.95(q2H), 2.55(s,
1H,C=CH), 1.96(m,2H).ppm.
FT-IR (KBr) 3647,3375,3289, 1671, 1634, 1601, 1582
cm-1.
maximum
wavelengths 35
UV-Vis
(CHCl3)
446,422,274,250 nm.
wherein R1 is one of O-CCH3 or O-C-CH2OH.;
A saturated solution of 17.5 mg (0.032 mmol) ceric
R2 is one of daunosamine, or H;
ammonium nitrate in acetone was added at 0 degrees
R3
is NO2; and
centigrade to pentahydroxynaphthacene (7ng, 0.016
R
is
OCH3, OH or H;
immol) and NaHCO3(10mg) in 2 mL of acetone. The
comprising the steps of:
reaction mixture was stirred for 5 h at room tempera
preparing a mono ketal of a 1,4-naphthoquinone as
ture and then filtered through Celite and extracted with
the precursor of the CD rings;
CH2Cl2 (7x10mL). Evaporation yielded 7 mg of the
preparing a precursor for Ring A with C6 and C11
amino trihydroxy-5,12-naphthacenone as purple red
attached and the stereochemistry at C7 and C9
crystals.
established and coupling it to CD and then con
1H NMR (CD2Cl2), 14.80(s, 1H,OH), 8.10 (d.1H),
pleting ring B;
7.85(t, 1H),742(d.1H),5.35(d, 1H)4.30(d,1H,OH), 4.09
said step of preparing a precursor for Ring A com
(s.3H),3.57(m,2H),3.35(m,1H,OH),3.15(m,2H),2.55(s,
prising the substeps of methylation of 5-oxocy
1H), 1.95(n,2H)ppm.
clohex-2-enecarboxylic acid to methyl 5-oxocy
UV-Vis (CHCL3) maximum wavelength: 498, 442, so
313, 269 mm.

FT-IROKBr) 3644, 3277, 1671, 1631, 1580 cm-l.
EXAMPLE 8

Daunomycinone
S5
A solution of 7 mg (0.018 mmol) of the amino-5,12
naphthacenedione and 1 mg of pyridinium tosylate in
2nL of dimethoxyethane was treated with 15 microL of
isoamylnitrite. As the mixture was stirred at room tem

perature a purple precipitate formed, and 0.5mL of 60

0.01N HCL was added, after stirring had been contin
ued for 5h, the visible spectrum of the mixture showed

absorption at 515 nm. Then HgO (40 mg, 0.18mmol),
was added and stirring was continued for 24 h. The
mixture was filtered through Celite, extracted with 65
CH2Cl2 (15x10mL) and evaporated to yield 10 mg of
red solid. Flash chromatogrphy with elution with ethyl
acetate:hexane:MeOH (90: 5:5), followed by recrystali

clohex-2-enecarboxylate at a reaction temperature
of between -20 to 20 degrees centigrade, trime
thylsilylethynylation of said cyclohexenecarboxy
late at a temperature of between -50 to -78 de
grees centigrade after removal of water and etha
nol to produce methyl cis-5-hydroxy-5-(trimethyl
silylethynyl)cyclohex-2-enecarboxylate, epoxida
tion to methyl cis-(2,3-epoxy-5-hydroxy)-5-(trime
thylsilyl ethynyl)cyclohexane-1-carboxylate and
opening of the resulting epoxide ring to give
methyl cis-3,5-dihydroxy-5-(trimethylsilylethynyl)

cyclohex-1-ene carboxylate.
2. A process according to claim 1 in which the mono

ketal of 1,4-naphthoquinone is the 4-monoketal of jug
lone methyl ether.
3. A process for the production of daunomycinone
and related compounds in accordance with claim 1 in
which the precursor for the A ring, with C6 and C1
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attached and the stereochemistry at C, and C9 estab

lished, has the general structure:

22

reducing said nitrodaunomycinone to 6-desoxy-6aminodaunomycinone;
converting said aminodaunomycinone to the 6
diazoniumdaunomycinone and from this obtaining
daunomycinone, 6-desoxydaunomycinone, the 6
desoxy-6-halodaunomycinones,
6-desoxy-6-

cyanodaunomycinone and other 6-analogues easily

derived from these products.
5. The process of claim 4, wherein the aprotic solvent
for condensing the acetonide with 1,4-dihydro-4,4,5wherein W is an ester or similar group capable of O trimethoxy-1-oxonaphthalene
can be acetonitrile, dime
acting as an electron pair acceptor in a Claisen thylsulfoxide, NNdimethylpropyleneurea
or hexame
condensation and related reactions;
X is an umpolung equivalent of an acetyl group such thylphosphoramide.
as acetylide, trimethylsilylacetylide, ethyl or 15 6. The process of claim 4, wherein the aprotic solvent
methyl vinyl ether, 2-methyl-1,3-dithiane or corre for condensing the acetonide is acetonitrile.
7. The process of claim 4, wherein said 1-oxotetrahy
sponding dithioacetal or dithioacetal oxide, or cy
dronaphthalene is cyclized with an alkalimetal alkoxide
naohydrin silyl ether or related compounds;
Y is 2H, or if needed, a suitable protecting group for of 1-6 carbon atoms.
a 1,3 diol, such as a cyclic ketal e.g. acetonide or a 20 8. The process of claim 7, wherein said alkali metal
alkoxide is sodium methoxide produced by potassium or
cyclic ester e.g. boronate or carbonate;
Z is a one carbon umpolung of carbonyl such as ni sodium hydride and a catalytic quantity of methanol in
tromethyl, 1,3-dithiane or the corresponding sulf toluene or other aprotic solvent.
9. The process of claim 4, wherein said decahydro-11
oxide of the 1,3-dithiane, a cyanohydrin silyl ether
naphthacenone
is converted to 7alpha,9alpha-(di-O-iso
or related compounds.
25
4. A process for the production of daunomycinone, propylidenyl)-4,5-dimethoxy-9beta-ethynyl-12
hydroxy-6-nitro-6,6a,7,8,9,10,10a, 11-octahydro-11
comprising the steps of
methylation of 5-oxocyclohex-2-enecarboxylic acid naphthacenone under acidic conditions.
10. The process of claim 4, wherein said decahydro
to methyl 5-oxocyclohex-2-enecarboxylate at a
11-naphthacenone is converted into said octahydro-11
reaction
temperature
of
between
-20
to
20
de
grees centigrade, trimethylsilylethynylation of said naphthacenone by treatment with pyridinium tosylate.
11. The process of claim 4, wherein said octahydro
oxocyclohexenecarboxylate at a temperature of
between -50 to -78 degrees centigrade after 11-naphthacenone is oxidized to 7alpha, 9alpha-(di-Oremoval of water and ethanol to produce methyl isopropylidenyl)-9beta-ethynyl-11-hydroxy-4-methoxy
cis-5-hydroxy-5-(trimethylsilylethynyl)cyclohex-2- 35 6-nitro-7,8,9,10-tetrahydro-5,12-naphthacenedione with
enecarboxylate, conversion to an epoxide and reagents such as cerium ammonium nitrate or thallium
opening of the resulting epoxide ring to give trinitrate or iodobenzenediacetate using with each oxi
methyl
cis-3,5-dihydroxy-5-(trimethylsilyl)e- dant a catalytic quantity of 2,3-dichloro-5,6dicyanobenzoquinone.
thynylcyclohex-1-enecarboxylate;
addition of nitromethane to the said dihydroxyethy
nyl ester to give methyl 3alpha,5alpha-dihydroxy

5beta-(trimethylsilylethynyl)-2alpha-nitromethyl

12. The process of claim 4, wherein the said di-O-iso

propylidenylethynyltetrahydro-5,12-naphthacenedione

is hydrolysed by acid in the presence of mercuric oxide
to 6-desoxy-6-nitrodaunomycinone.
13. The process of claim 4, wherein the said ni
dihydroxy-5-beta-(trimethylsilylethynyl)-2alpha 45 trodaunomycinone is reduced to 6-amino-6-desox
ydaunomycinone using SnCl2 in the presence of sodium
nitromethylcyclohexane-1-beta-carboxylate;
condensation of the said acetonide with 1,4-dihydro acetate in methanol.
14. The process of claim 4, wherein the said
4,4,5-trimethoxy-1-oxonaphthalene in the presence
of 1,8-diazabicyclo5.4.0 undec-7-ene in an aprotic aminodaunomycinone is converted via a diazonium
solvent to produce 3-2beta-carbomethoxy-4-beta intermediate into one of daunomycinone, 6-desox
ydaunomycinone, the 6-desoxy- 6-halodaunomyci
ethynyl-4-alpha,6alpha-(di-O-isopropylidenyl)cy
clohexan-1alpha-yl)-nitromethyl-4,4,5-trimethoxy nones, 6-desoxy-6-cyanodaunomycinone and com
pounds easily derived from these products.
1-oxo-1,2,3,4-tetrahydronaphthalene;
15. The process of claim 14, wherein said diazonium
cyclizing said 1-oxotetrahydronaphthalene to pro
duce 7alpha,9alpha-(di-O-isopropylidenyl)-9beta 55 compound is formed from the amino daunomycinone in
1,2-dimethoxyethone using amyl nitrite in the presence
ethynyl-12-hydroxy-6-nitro-4,5,5-trimethoxy
5,5a,6, 6a,7,8,9,10,10a, 11-decahydro-11-naphthace of pyridinium tosylate.
16. The process of claim 4 wherein said decahydro
none;
converting said decahydro-11-naphthacenone to 7al 11-naphthacenone is hydrolyzed by HgO in the pres
pha,9alpha-(di-O-isopropylidenyl)-4,5-dimethoxy ence of acid to form 9beta-acetyl-4,5-dimethoxy-6nitro-7alpha,9alpha, 12-trihydroxy-6,6a, 7,8,9,10,10a, 11
9beta-ethynyl-12-hydroxy-6-nitro-6,6a,7,8,9,10,octahydro-11-naphthacenone.
10a, 11-octahydro-11-naphthacenone;
17. The process of claim 4, wherein the said 9beta
oxidizing said octahydro-11-naphthacenone to 7al
pha,9alpha-(di-O-isopropylidenyl)-9beta-ethynyl acetyloctahydro-11-naphthacenone is oxidized to 6
11-hydroxy-4-methoxy-6-nitro-7,8,9,10-tetrahy 55 desoxy-6-nitrodaunomycinone with thallium trinitrate

hexane-1beta-carboxylate;
formation of the acetonide of methyl 3alpha,5alpha

dro-5,12-naphthacenedione;
hydrolysing said 5,12-naphthacenedione to 6-desoxy
6-nitrodaunomycinone;

or cerium ammonium nitrate or iodobenzenediacetate

using with each oxidant a catalytic quantity of 2,3-

dichloro-5,6-dicyanobenzoquinone.
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18. The process of claim 4 wherein said 9beta
acetyloctahydro-11-naphthacenone is oxidized with

24

24. A process for producing methyl 3alpha,5alpha
dihydroxy-5beta-ethynyl-2alpha-nitro-methylcyclohex
ane-1beta-carboxylate comprising the steps of reacting
cerium ammonium nitrate or thallium trinitrate or iodo
cis-3,5-dihydroxy-5-beta-ethynylcyclohex
benzene diacetate to 9beta-acetyl-7alpha,9alpha-dihy methyl
droxy-4-methoxy-6-nitro-6,6a,7,8, 9,10,10a, 11-octahy 1-ene-1-carboxylate with nitromethane in the presence
of 1,8-diazabicyclo5.4.0]undec-7-ene or 1,5-diazabicy
dro-5,11,12-naphthacenetrione.
4.3.0 non-5-ene or sodium hydride or potassium
19. The process of claim 4, wherein the alkali metal cio
hydride
in an aprotic solvent that can form hydrogen
alkoxide is sodium methoxide generated from sodium bonds with
hydroxyl groups.
hydride and a catalytic quantity of methanol in toluene. 10 25. The process
of claim 23 carried out in the pres
20. The process of claim 4, wherein the aprotic sol ence of 1,8-diazabicyclo[5.4.0]undec-7-ene,
wherein the
vent for condensing the acetonide with 1,4-dihydro aprotic
solvent
is
dimethyl
sulfoxide.
4,4,5-trimethoxy-1-oxonaphthalene is acetonitrile; the
26. The process of claim 23 carried out in the pres
thus-produced 1-oxotetrahydronaphthalene is cyclized ence
of sodium hydride, wherein the aprotic solvent is
with sodium methoxide; the thus-produced decahydro 15 dimethyl
sulfoxide.
11-naphthacenone is converted to the 9beta-acetyloc
27. A process for preparing methyl 3-alpha,5-alpha
tahydro-1-naphthacenone with mercuric oxide in an dihydroxy-5-beta-(trimethylsilylethynyl)-2alpha
acidic medium; the thus-produced 9beta-acetyloctahy nitromethylcyclohexane-1-beta-carboxylate comprising
dro-11-naphthacenone is oxidized to the decahydro reacting methyl cis-(2,3alpha-epoxy-5alpha-hydroxy
5,11,12-naphthacenetrione with thallium trinitrate or 20 5beta-(trimethylsilylethynyl)cyclohexane-1alpha-car
cerium ammonium nitrate or iodobenzenediacetate; the boxylate with nitromethane in the presence of 1,8thusproduced decahydro-5,11,12-naphthacenetrione is diazabicyclo5.4.0]undec-7-ene in an aprotic solvent.
converted to a daunomycinone titanium compound by a
28. The process of claim 27, wherein the aprotic sol
Nef reaction, using sodium methoxide, and a thus vent is dimethyl sulfoxide.
formed intermediate is treated with titanium trichloride.
29. Methyl 3alpha,5alpha-dihydroxy-5beta-(trime
21. A process of synthesizing methyl cis-3,5-dihy thylsilylethynyl)-2alpha-nitromethylcyclohexane
droxy-5-(trimethylsilylethynyl)cyclohex-1-ene-1-car
beta-carboxylate.
boxylate from m-anisic acid comprising the steps of
30. The 3,5-acetonide of methyl 3alpha,5alpha-dihy
Birch reduction with lithium in ammonia to produce droxy-5beta-(trimethylsilylethynyl)-2alpha-nitrome
5-oxocyclohex-2-ene-1-carboxylic acid, methylation of 30 thylcyclohexane-1beta-carboxylate.
31. A process for preparing the compound of claim
said cyclohex-2-ene-1-carboxylic acid to methyl 5-oxo
cyclohex-2-ene-1-carboxylate with diazomethane, 30, comprising reacting 3alpha,5alpha-dihydroxy-5beta
trimethylsilylethynylation of said cyclohex-2-ene-l-car (trimethylsilylethynyl)-2alpha-nitromethylcyclohex
boxylate with cerium dichloride trimethylsilylacetylene ane-1beta-carboxylate with an acetonide-forming rea
to produce methyl cis-5-hydroxy-5-(trimethylsilyle 35 gent.
32. The process of claim 31, wherein the acetonide
thynyl)cyclohex-2-ene-1-carboxylats, and conversion
to an epoxide and opening of the resulting epoxide ring forming reagent is 2-methoxypropene and acetonide
formation is carried out in the presence of pyridinium
to give said cyclohex-1-ene-1-carboxylate.
tosylate.
22. The process of claim 21 wherein:
33. The process of converting 5-alkoxy-1-naphthol to
the reaction mixture is kept cold during esterification a corresponding
juglone alkyl ether 4-acetal, by reac
with diazomethane and the ethanol that is present tion thallium trinitrate
or iodobenzenediacetate in tri
in the esterification reaction mixture is removed by methyl orthoformate and
the appropriate solvent to
azeotropic distillation with benzene;
provide
the
ketal.
methyl ester is treated with cerium dichloride trime 45 34. The process of claim 33, wherein the 5-alkoxy-1thylsilylacetylene at a low temperature to prevent naphthol is 5-methoxy-1-naphthol, the oxident is iodo
formation of a lactone;

the solvent is methanol and trime
the epoxide is formed by oxidation with t-butyl hy benzenediacetate,
thylorthoformate
and
bicarbonate is present,
droperoxide in the presence of molybdenum hex and the thus-produced sodium
juglone alkyl ether ketal is 1,4acarbonyl catalyst and isolating the thus-produced dihydro-4,4,5-trimethoxy-1-oxonaphthalene.
epoxide; and
35. The process of claim 24 carried out in the pres
the epoxide ring is opened with 1,8-diazabicyclo ence
of 1,8-diazabicyclo5.4.0]undec-7-ene, wherein the
5.4.0-undec-7-ene or 1,5-diazabicyclo 4.3.0non aprotic solvent is dimethyl sulfoxide.
5-ene or sodium methoxide in methanol; the latter
36. The process of claim 24 carried out in the pres
conditions also remove the trimethysilyl group to 55 ence
of sodium hydride, wherein the aprotic solvent is
give methyl cis 3,5-dihydroxy-5-ethynylcyclohex dimethyl
sulfoxide.
1-ene-1-carboxylate.
37. A method according to claim 1 further compris
23. A process for producing methyl 3alpha,5alpha ing the steps of
dihydroxy-5beta-(trimethylsilylethynyl)-2alpha
adding nitromethane to the said dihydroxyethynyl
nitromethylcyclohexane-1beta-carboxylate comprising 60
ester to give methyl 3alpha,5alpha-dihydroxy
the steps of reacting methyl cis-3,5-dihydroxy-5-(trime
5beta-(trimethylsilylethynyl)-2alpha-nitromethyl
thylsilylethynyl)cyclohex-1-ene-1-carboxylate with ni
hexane-1beta-carboxylate; and
tromethane in the presence of 1,8-diazabicyclo[5.4.0]un
forming the acetonide of methyl 3alpha,5alpha-dihy
droxy-5beta-(trimethylsilylethynyl)-2alpha
dec-7-ene or 1,5-diazabicyclo-4.3.0non-5-ene or sodium
nitromethylcyclohexane-1beta-carboxylate.
hydride in an aprotic solvent that can form hydrogen
bonds with hydropyl groups.

